Shares of Bionano Genomics fell by a staggering 25.72% in 30 days from $-19.81 to $5.91 at 21:00 EST on Wednesday, following last session’s upward trend. NASDAQ Composite is jumping 1.19% to $13,950.22, after two sequential sessions in a row of losses. This seems, so far, an all-around positive trend exchanging session today.
Bionano Genomics’s last close was $5.38, 165.48% below its 52-week high of $15.69.
Bionano Genomics’s Sales
Bionano Genomics’s sales growth is 154.4% for the ongoing quarter and 203.7% for the next. The company’s growth estimates for the present quarter and the next is 86.7% and 44.4%, respectively.
Bionano Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.
Bionano Genomics’s Stock Yearly Top and Bottom Value
Bionano Genomics’s stock is valued at $5.91 at 21:00 EST, way under its 52-week high of $15.69 and way higher than its 52-week low of $0.28.
Bionano Genomics’s Moving Average
Bionano Genomics’s worth is way below its 50-day moving average of $9.47 and way above its 200-day moving average of $4.64.
More news about Bionano Genomics.